Press Releases

Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

Andelyn Biosciences, a gene therapy CDMO, has joined forces with Purespring Therapeutics to accelerate the development of gene therapies for chronic kidney diseases. Purespring is known for its innovative treatments that can slow or halt these diseases. The partnership leverages Andelyn's AAV production expertise and suspension platform under GMP to expedite the clinical advancement of Purespring's therapies. Both organizations share a commitment to improving human health through gene therapies. This collaboration will benefit from Andelyn's advanced GMP manufacturing capabilities in Columbus, Ohio, and is poised to offer hope to patients with kidney diseases.

Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited

BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.

Cresset Targets International Growth with Innovate UK Scaleup Programme

Drug discovery specialists Cresset has joined Innovate UK’s Scaleup Programme for businesses with high growth potential

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights

CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology

CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

JPA HEALTH EXPANDS LIFE SCIENCES DIVISION WITH ACQUISITION OF TRUE NORTH SOLUTIONS, INC.

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations

Inizio Engage launches new global powerhouse learning brand, Nazaré

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.

Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access

Avania, a leading, global medical technology contract research organization (CRO), today announced its acquisition of HULL ASSOCIATES LLC and Ironstone Product Development (IPD) with a view toward addressing MedTech’s emerging priorities in regulatory and reimbursement and building scale to offer thoughtful strategies and differentiated project delivery for all product categories.

Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO

Expanding Research Horizons: CD Formulation Unveils its Redesigned Collection of Pharmaceutical Excipients

Unleashing Diamond's Full Potential: Alfa Chemistry's Single Crystalline and Polycrystalline Diamond Transformations

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults. The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.2,3 If approved by the European Medicines Agency, rezafungin could be the first new treatment option in over 10 years for patients with invasive candidiasis.4

WCG Raises the Bar in Quality Management Standards, Becoming ISO 9001 Certified in both IRB and IBC

WCG has now achieved ISO 9001 certification for its Institutional Biosafety Committee (IBC) services as well as its Institutional Review Board (IRB) services, emphasizing its commitment to excellence in quality management across ethical review.